United States (US) NGS Based Molecular Diagnostic Market (2025-2031) | Outlook, Industry, Segmentation, Forecast, Size & Revenue, Companies, Share, Trends, Value, Analysis, Competitive Landscape, Growth

Name: United States (US) NGS Based Molecular Diagnostic Market (2025-2031) | Outlook & Industry
Creator: 6Wresearch
License: https://www.6wresearch.com/privacy-policy

Market Forecast By Application (Microbiology, Infectious Diseases, Oncology, Genetic Tests, Other Applications), By End Users (Research Centres and Academics, Hospitals and Clinical Laboratories, Others) And Competitive Landscape

Product Code: ETC9971067	Publication Date: Sep 2024	Updated Date: Aug 2025	Product Type: Market Research Report
Publisher: 6Wresearch	Author: Dhaval Chaurasia	No. of Pages: 75	No. of Figures: 35	No. of Tables: 20

Key Highlights of the Report:

United States (US) NGS Based Molecular Diagnostic Market Outlook
Market Size of United States (US) NGS Based Molecular Diagnostic Market, 2024
Forecast of United States (US) NGS Based Molecular Diagnostic Market, 2031
Historical Data and Forecast of United States (US) NGS Based Molecular Diagnostic Revenues & Volume for the Period 2021- 2031
United States (US) NGS Based Molecular Diagnostic Market Trend Evolution
United States (US) NGS Based Molecular Diagnostic Market Drivers and Challenges
United States (US) NGS Based Molecular Diagnostic Price Trends
United States (US) NGS Based Molecular Diagnostic Porter's Five Forces
United States (US) NGS Based Molecular Diagnostic Industry Life Cycle
Historical Data and Forecast of United States (US) NGS Based Molecular Diagnostic Market Revenues & Volume By Application for the Period 2021- 2031
Historical Data and Forecast of United States (US) NGS Based Molecular Diagnostic Market Revenues & Volume By Microbiology for the Period 2021- 2031
Historical Data and Forecast of United States (US) NGS Based Molecular Diagnostic Market Revenues & Volume By Infectious Diseases for the Period 2021- 2031
Historical Data and Forecast of United States (US) NGS Based Molecular Diagnostic Market Revenues & Volume By Oncology for the Period 2021- 2031
Historical Data and Forecast of United States (US) NGS Based Molecular Diagnostic Market Revenues & Volume By Genetic Tests for the Period 2021- 2031
Historical Data and Forecast of United States (US) NGS Based Molecular Diagnostic Market Revenues & Volume By Other Applications for the Period 2021- 2031
Historical Data and Forecast of United States (US) NGS Based Molecular Diagnostic Market Revenues & Volume By End Users for the Period 2021- 2031
Historical Data and Forecast of United States (US) NGS Based Molecular Diagnostic Market Revenues & Volume By Research Centres and Academics for the Period 2021- 2031
Historical Data and Forecast of United States (US) NGS Based Molecular Diagnostic Market Revenues & Volume By Hospitals and Clinical Laboratories for the Period 2021- 2031
Historical Data and Forecast of United States (US) NGS Based Molecular Diagnostic Market Revenues & Volume By Others for the Period 2021- 2031
United States (US) NGS Based Molecular Diagnostic Import Export Trade Statistics
Market Opportunity Assessment By Application
Market Opportunity Assessment By End Users
United States (US) NGS Based Molecular Diagnostic Top Companies Market Share
United States (US) NGS Based Molecular Diagnostic Competitive Benchmarking By Technical and Operational Parameters
United States (US) NGS Based Molecular Diagnostic Company Profiles
United States (US) NGS Based Molecular Diagnostic Key Strategic Recommendations

Frequently Asked Questions About the Market Study (FAQs):

How does 6Wresearch market report help businesses in making strategic decisions?

Do you also provide customisation in the market study?

1 Executive Summary

2 Introduction

2.1 Key Highlights of the Report

2.2 Report Description

2.3 Market Scope & Segmentation

2.4 Research Methodology

2.5 Assumptions

3 United States (US) NGS Based Molecular Diagnostic Market Overview

3.1 United States (US) Country Macro Economic Indicators

3.2 United States (US) NGS Based Molecular Diagnostic Market Revenues & Volume, 2021 & 2031F

3.3 United States (US) NGS Based Molecular Diagnostic Market - Industry Life Cycle

3.4 United States (US) NGS Based Molecular Diagnostic Market - Porter's Five Forces

3.5 United States (US) NGS Based Molecular Diagnostic Market Revenues & Volume Share, By Application, 2021 & 2031F

3.6 United States (US) NGS Based Molecular Diagnostic Market Revenues & Volume Share, By End Users, 2021 & 2031F

4 United States (US) NGS Based Molecular Diagnostic Market Dynamics

4.1 Impact Analysis

4.2 Market Drivers

4.2.1 Increasing prevalence of chronic diseases requiring molecular diagnostics

4.2.2 Technological advancements in next-generation sequencing (NGS) techniques

4.2.3 Growing adoption of personalized medicine and targeted therapies

4.3 Market Restraints

4.3.1 High cost associated with NGS-based molecular diagnostics

4.3.2 Regulatory challenges and stringent approval processes

4.3.3 Lack of skilled professionals in the field of molecular diagnostics

5 United States (US) NGS Based Molecular Diagnostic Market Trends

6 United States (US) NGS Based Molecular Diagnostic Market, By Types

6.1 United States (US) NGS Based Molecular Diagnostic Market, By Application

6.1.1 Overview and Analysis

6.1.2 United States (US) NGS Based Molecular Diagnostic Market Revenues & Volume, By Application, 2021- 2031F

6.1.3 United States (US) NGS Based Molecular Diagnostic Market Revenues & Volume, By Microbiology, 2021- 2031F

6.1.4 United States (US) NGS Based Molecular Diagnostic Market Revenues & Volume, By Infectious Diseases, 2021- 2031F

6.1.5 United States (US) NGS Based Molecular Diagnostic Market Revenues & Volume, By Oncology, 2021- 2031F

6.1.6 United States (US) NGS Based Molecular Diagnostic Market Revenues & Volume, By Genetic Tests, 2021- 2031F

6.1.7 United States (US) NGS Based Molecular Diagnostic Market Revenues & Volume, By Other Applications, 2021- 2031F

6.2 United States (US) NGS Based Molecular Diagnostic Market, By End Users

6.2.1 Overview and Analysis

6.2.2 United States (US) NGS Based Molecular Diagnostic Market Revenues & Volume, By Research Centres and Academics, 2021- 2031F

6.2.3 United States (US) NGS Based Molecular Diagnostic Market Revenues & Volume, By Hospitals and Clinical Laboratories, 2021- 2031F

6.2.4 United States (US) NGS Based Molecular Diagnostic Market Revenues & Volume, By Others, 2021- 2031F

7 United States (US) NGS Based Molecular Diagnostic Market Import-Export Trade Statistics

7.1 United States (US) NGS Based Molecular Diagnostic Market Export to Major Countries

7.2 United States (US) NGS Based Molecular Diagnostic Market Imports from Major Countries

8 United States (US) NGS Based Molecular Diagnostic Market Key Performance Indicators

8.1 Average turnaround time for NGS-based diagnostic tests

8.2 Rate of adoption of NGS technologies in clinical settings

8.3 Number of partnerships and collaborations between diagnostic companies and research institutions in the US

8.4 Percentage of research funding allocated to NGS-based molecular diagnostics in the US

9 United States (US) NGS Based Molecular Diagnostic Market - Opportunity Assessment

9.1 United States (US) NGS Based Molecular Diagnostic Market Opportunity Assessment, By Application, 2021 & 2031F

9.2 United States (US) NGS Based Molecular Diagnostic Market Opportunity Assessment, By End Users, 2021 & 2031F

10 United States (US) NGS Based Molecular Diagnostic Market - Competitive Landscape

10.1 United States (US) NGS Based Molecular Diagnostic Market Revenue Share, By Companies, 2024

10.2 United States (US) NGS Based Molecular Diagnostic Market Competitive Benchmarking, By Operating and Technical Parameters

11 Company Profiles

12 Recommendations

13 Disclaimer

Africa NGS Based Molecular Diagnostic Market

Estonia NGS Based Molecular Diagnostic Market

Ethiopia NGS Based Molecular Diagnostic Market

Fiji NGS Based Molecular Diagnostic Market

Finland NGS Based Molecular Diagnostic Market

Gabon NGS Based Molecular Diagnostic Market

Global NGS Based Molecular Diagnostic Market

Middle East NGS Based Molecular Diagnostic Market

North America NGS Based Molecular Diagnostic Market

Export potential assessment - trade Analytics for 2030

Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.

By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.

To discover high-growth global markets and optimize your business strategy:

Click Here